Liangdi Jiang

719 total citations
15 papers, 570 citations indexed

About

Liangdi Jiang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Liangdi Jiang has authored 15 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Biomaterials. Recurrent topics in Liangdi Jiang's work include Nanoplatforms for cancer theranostics (6 papers), Extracellular vesicles in disease (5 papers) and RNA Interference and Gene Delivery (5 papers). Liangdi Jiang is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Extracellular vesicles in disease (5 papers) and RNA Interference and Gene Delivery (5 papers). Liangdi Jiang collaborates with scholars based in China, Pakistan and Portugal. Liangdi Jiang's co-authors include Jiyong Liu, Yongwei Gu, Yue Du, Yunan Zhao, Aixue Li, Xiaomeng Tang, Ziwen Du, Liqiu Zhang, Xin Wu and Mingfeng Qiu and has published in prestigious journals such as Journal of Hazardous Materials, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

In The Last Decade

Liangdi Jiang

15 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangdi Jiang China 11 348 191 132 115 75 15 570
Yao Jiang China 15 202 0.6× 124 0.6× 92 0.7× 90 0.8× 27 0.4× 32 460
Ayman Shafei Egypt 14 369 1.1× 107 0.6× 191 1.4× 135 1.2× 43 0.6× 23 827
Xiaochen Liu China 14 277 0.8× 44 0.2× 80 0.6× 40 0.3× 30 0.4× 40 708
Minzhao Lin China 16 187 0.5× 285 1.5× 58 0.4× 134 1.2× 162 2.2× 29 592
Wenpan Li China 18 254 0.7× 267 1.4× 29 0.2× 225 2.0× 160 2.1× 38 753
Changlong Wang China 7 167 0.5× 159 0.8× 44 0.3× 73 0.6× 132 1.8× 17 401
Bi‐Wen Yeh Taiwan 18 311 0.9× 83 0.4× 129 1.0× 51 0.4× 57 0.8× 33 681
Xilan Li China 11 344 1.0× 335 1.8× 28 0.2× 87 0.8× 21 0.3× 12 652
Yuxiang Sun China 15 260 0.7× 134 0.7× 84 0.6× 76 0.7× 37 0.5× 35 566

Countries citing papers authored by Liangdi Jiang

Since Specialization
Citations

This map shows the geographic impact of Liangdi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangdi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangdi Jiang more than expected).

Fields of papers citing papers by Liangdi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangdi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangdi Jiang. The network helps show where Liangdi Jiang may publish in the future.

Co-authorship network of co-authors of Liangdi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangdi Jiang. A scholar is included among the top collaborators of Liangdi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangdi Jiang. Liangdi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Shulei, Faisal Raza, Liangdi Jiang, et al.. (2024). Nanovaccine of tumor-derived antigenic microparticles for enhancing effect of arsenic trioxide in cancer immunotherapy. Nano Today. 57. 102321–102321. 3 indexed citations
2.
3.
4.
Li, Kunwei, Faisal Raza, Liangdi Jiang, Jing Su, & Mingfeng Qiu. (2024). Clerodendranthus Spicatus: A review of its active compounds, mechanisms of action, and clinical studies in urinary diseases. Fitoterapia. 177. 106082–106082. 2 indexed citations
5.
Raza, Faisal, Liangdi Jiang, Steven S.-L. Zhang, et al.. (2024). SP94 engineered erythrocyte membrane enhanced the targeted delivery of biomimetic nanosuspension with IDO immunotherapy and chemotherapy in liver cancer. Chemical Engineering Journal. 491. 151709–151709. 5 indexed citations
6.
Xu, Jiacan, Yao Tong, Liangdi Jiang, et al.. (2023). Carbon-defect-driven persulfate activation for highly efficient degradation of extracellular DNA contaminant: Radical oxidation and electron transfer pathways. Journal of Hazardous Materials. 447. 130817–130817. 35 indexed citations
7.
Raza, Faisal, Hajra Zafar, Liangdi Jiang, et al.. (2023). Progress of cell membrane-derived biomimetic nanovesicles for cancer phototherapy. Biomaterials Science. 12(1). 57–91. 10 indexed citations
8.
Jiang, Liangdi, Xuerui Wang, Faisal Raza, et al.. (2023). PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy. Biomaterials Science. 11(15). 5301–5319. 15 indexed citations
9.
Gu, Yongwei, Yue Du, Liangdi Jiang, et al.. (2022). αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma. Journal of Nanobiotechnology. 20(1). 384–384. 51 indexed citations
10.
Kamal, Zul, Jing Su, Weien Yuan, et al.. (2022). Red blood cell membrane-camouflaged vancomycin and chlorogenic acid-loaded gelatin nanoparticles against multi-drug resistance infection mice model. Journal of Drug Delivery Science and Technology. 76. 103706–103706. 17 indexed citations
11.
Jiang, Liangdi, Yongwei Gu, Yue Du, et al.. (2021). Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy. ACS Applied Materials & Interfaces. 13(36). 42411–42428. 65 indexed citations
12.
Zhao, Yunan, Aixue Li, Liangdi Jiang, Yongwei Gu, & Jiyong Liu. (2021). Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications. Biomacromolecules. 22(8). 3149–3167. 90 indexed citations
13.
Tang, Xiaomeng, Meng Yang, Yongwei Gu, et al.. (2021). Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis. Drug Design Development and Therapy. Volume 15. 4105–4123. 11 indexed citations
14.
Li, Aixue, et al.. (2021). Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Delivery. 28(1). 1237–1255. 103 indexed citations
15.
Jiang, Liangdi, Yongwei Gu, Yue Du, & Jiyong Liu. (2019). Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer. Molecular Pharmaceutics. 16(8). 3333–3349. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao Jiang Breakdown of academic impact, for papers by Ayman Shafei Breakdown of academic impact, for papers by Xiaochen Liu Breakdown of academic impact, for papers by Minzhao Lin Breakdown of academic impact, for papers by Wenpan Li Breakdown of academic impact, for papers by Changlong Wang Breakdown of academic impact, for papers by Bi‐Wen Yeh Breakdown of academic impact, for papers by Xilan Li Breakdown of academic impact, for papers by Yuxiang Sun
Rankless by CCL
2026